The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)

Alan Douglas Tice

Infections Limited Hawaii


Hawaii 96814



Name/email consistency: high



  • Infections Limited Hawaii, Honolulu, Hawaii 96814, USA. 2011 - 2012
  • John A. Burns School of Medicine, University of Hawaii, Honolulu, Hawaii, USA. 2004 - 2010
  • Infections Limited, P.S., Tacoma, WA 98402, USA. 1999 - 2003
  • Outpatient Parenteral Antibiotic Therapy (OPAT), Outcomes Registry, Tacoma, Washington 98402, USA. 2002
  • University of Washington School of Medicine, Seattle, Wash., USA. 2001
  • University of Washington, Seattle, USA. 2000


  1. Oritavancin: a new opportunity for outpatient therapy of serious infections. Tice, A. Clin. Infect. Dis. (2012) [Pubmed]
  2. Access to care: the physician's perspective. Tice, A., Ruckle, J.E., Sultan, O.S., Kemble, S. Hawaii. Med. J (2011) [Pubmed]
  3. Meeting the challenges of methicillin-resistant Staphylococcus aureus with outpatient parenteral antimicrobial therapy. Tice, A.D., Rehm, S.J. Clin. Infect. Dis. (2010) [Pubmed]
  4. Quantitation of Staphylococcus aureus in seawater using CHROMagar SA. Tice, A.D., Pombo, D., Hui, J., Kurano, M., Bankowski, M.J., Seifried, S.E. Hawaii. Med. J (2010) [Pubmed]
  5. Knowledge of severe acute respiratory syndrome among community physicians, nurses, and emergency medical responders. Tice, A.D., Kishimoto, M., Dinh, C.H., Lam, G.T., Marineau, M. Prehosp. Disaster. Med (2006) [Pubmed]
  6. Ertapenem: a new opportunity for outpatient parenteral antimicrobial therapy. Tice, A.D. J. Antimicrob. Chemother. (2004) [Pubmed]
  7. Practice guidelines for outpatient parenteral antimicrobial therapy. IDSA guidelines. Tice, A.D., Rehm, S.J., Dalovisio, J.R., Bradley, J.S., Martinelli, L.P., Graham, D.R., Gainer, R.B., Kunkel, M.J., Yancey, R.W., Williams, D.N. Clin. Infect. Dis. (2004) [Pubmed]
  8. Risk factors and treatment outcomes in osteomyelitis. Tice, A.D., Hoaglund, P.A., Shoultz, D.A. J. Antimicrob. Chemother. (2003) [Pubmed]
  9. Outcomes of osteomyelitis among patients treated with outpatient parenteral antimicrobial therapy. Tice, A.D., Hoaglund, P.A., Shoultz, D.A. Am. J. Med. (2003) [Pubmed]
  10. Cost perspectives for outpatient intravenous antimicrobial therapy. Tice, A.D., Hoaglund, P.A., Nolet, B., McKinnon, P.S., Mozaffari, E. Pharmacotherapy (2002) [Pubmed]
  11. Outpatient parenteral antimicrobial therapy (OPAT): a global perspective. Introduction. Tice, A. Chemotherapy (2001) [Pubmed]
  12. The use of outpatient parenteral antimicrobial therapy in the management of osteomyelitis: data from the Outpatient Parenteral Antimicrobial Therapy Outcomes Registries. Tice, A. Chemotherapy (2001) [Pubmed]
  13. Pharmacoeconomic considerations in the ambulatory use of parenteral cephalosporins. Tice, A.D. Drugs (2000) [Pubmed]
  14. Outpatient parenteral antimicrobial therapy for central nervous system infections. Tice, A.D., Strait, K., Ramey, R., Hoaglund, P.A. Clin. Infect. Dis. (1999) [Pubmed]
WikiGenes - Universities